2015
DOI: 10.1016/j.ygyno.2015.03.055
|View full text |Cite
|
Sign up to set email alerts
|

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 24 publications
(28 citation statements)
references
References 33 publications
1
27
0
Order By: Relevance
“…To profile a range of biological functions including metabolism, enzyme ‘Asparaginase-Like 1’ (ASRGL1; aka ALP1) was chosen for immunofluorescence analysis. ASRGL1 is known to catalyze the hydrolysis of L-asparagine 40 and to clear protein-damaging isoaspartyl-peptides 41 , and while largely uncharacterized in the mouse, has been found to be highly expressed in the human cervix, fallopian tube, ovary, and testis 42 . Interestingly, ASRGL1 has been identified as a biomarker of endometrial cancer 4245 , as well as an antigen in rodent sperm 46 .…”
Section: Resultsmentioning
confidence: 99%
“…To profile a range of biological functions including metabolism, enzyme ‘Asparaginase-Like 1’ (ASRGL1; aka ALP1) was chosen for immunofluorescence analysis. ASRGL1 is known to catalyze the hydrolysis of L-asparagine 40 and to clear protein-damaging isoaspartyl-peptides 41 , and while largely uncharacterized in the mouse, has been found to be highly expressed in the human cervix, fallopian tube, ovary, and testis 42 . Interestingly, ASRGL1 has been identified as a biomarker of endometrial cancer 4245 , as well as an antigen in rodent sperm 46 .…”
Section: Resultsmentioning
confidence: 99%
“…Protein expression assessed by IHC staining is found to be relatively similar in curettage samples and corresponding hysterectomy specimens for several markers (concordance rates of 70–100%), suggesting that immunohistochemical evaluation of curettage specimens may aid in the identification of high‐risk cases before surgery . Loss of ASRGL1 expression in the hysterectomy specimen is found to independently predict aggressive disease and poor disease‐specific survival in women with endometrial carcinoma . Less is known about ASRGL1 expression in preoperative samples, but combined low expression of ASRGL1 and PR was recently reported to predict high FIGO stage (III–IV) among women with endometrioid endometrial carcinoma .…”
Section: Discussionmentioning
confidence: 98%
“…The optimal staining evaluation and cut‐off for ASRGL1 need to be standardised before clinical implementation. However, different methods (the staining index versus percentage of cells with positive staining) for evaluation of ASGRL1 expression have been published with very similar results, indicating that ASRGL1 might be a robust biomarker.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations